Brain implant trial offers hope for kids with untreatable seizures
NCT ID NCT06924086
Summary
This study is testing whether a surgically implanted brain stimulation device can reduce seizure frequency in children with Lennox-Gastaut syndrome, a severe form of epilepsy. Children aged 5-14 who haven't responded to medications will have the device implanted and be randomly assigned to have it turned on immediately or after a delay. The trial measures how much the device reduces seizures and improves quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LENNOX GASTAUT SYNDROME (LGS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.